REDEXAM - Reducing Painful Eye Examinations in Preterm Infants (REDEXAM)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01861470|
Recruitment Status : Completed
First Posted : May 23, 2013
Last Update Posted : October 12, 2015
More than 8000 babies born >8 weeks early or weighing less than 1500g at birth in the United Kingdom annually are at risk of a serious eye problem - retinopathy of prematurity (ROP). Less than 1 in 10 need treating, but to identify these all of them require eye examinations 1-2 weekly from 5 weeks. These tests are uncomfortable, upsetting for families, and cost considerable time and money.
There is now a new urine test that might help identify babies with the highest risk of developing significant ROP. This cheap test appears to predict which babies need treatment and could avoid invasive eye examination in thousands of babies. The test has so far only been used in 136 babies. It accurately predicted ROP, but 136 babies cannot change practice. We need to test more babies including in the UK. This study is designed to test >300 UK babies to see how accurately urine levels of NTproBNP predict development of ROP needing treatment.
We will also pool our data with other researchers across Europe testing the same test to identify the best 'cut'-off' value for this test. In the future babies with urine levels of this chemical lower than this cut-off level would not need invasive eye examinations.
If this test works as we hope it will many babies will avoid repeated painful eye tests, and their families will be saved the stress of watching this being done, by replacing these with a simple easy cheap pain free urine test. There will be substantial savings in health care costs that could be used to improve other aspects of care. In resource poor settings without an expert ophthalmologist babies could be screened for ROP that currently cannot be screened.
We hope to demonstrate this to be a family-friendly, achievable intervention that positively impacts on the lives of babies and families experiencing neonatal intensive care.
|Condition or disease|
|Retinopathy of Prematurity|
|Study Type :||Observational|
|Actual Enrollment :||500 participants|
|Official Title:||Reducing Painful Eye Examinations in Preterm Infants|
|Study Start Date :||November 2013|
|Actual Primary Completion Date :||July 2015|
|Actual Study Completion Date :||July 2015|
all <32 weeks
- the ability of urinary NTproBNP (normalised to creatinine) at 14 days of age and 28 days to predict severity of ROP [ Time Frame: day 14 and day 28 ]
- Receiver operator characteristics curve, sensitivity, specificity, positive and negative predictive values. [ Time Frame: day 14 and day 28 ]
Biospecimen Retention: Samples Without DNA
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01861470
|Janet Berrington, Newcastle Neonatal Service|
|Newcastle, Tyne and Wear, United Kingdom, NE1 4LP|
|Principal Investigator:||Janet Berrington, MD||Newcastle-upon-Tyne Hospitals NHS Trust|